Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama



Read more
9,554 registered articles
(updated on August 20, 2018)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
1.694
2017 IMPACT FACTOR
JOURNALS PEER REVIEWED FREE ACCESS FULL-TEXT HTML ADVANCE PUBLICATION
Featured article
Volume 41 (2018) Issue 7 Pages 1078-1083
Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice Read more
Editor’s picks

Exosomes are extracellular vesicles released by various types of cells, including immune cells and cancer cells. The article by Emam et al evaluated in vivo secretion of exosomes following intravenous injection of free doxorubicin (DXR) or liposomal DXR (Doxil®) was evaluated using normal mice. Free DXR treatment markedly increased the serum exosome level, while Doxil® treatment did not change. Interestingly, splenectomy significantly suppressed the exosomal secretions induced by free DXR treatment. Their results suggest that conventional anticancer agents induce the secretion of exosomes via stimulating immune cells of the spleen, and might contribute to the antitumor effect of chemotherapeutic agents.

View the past featured articles
Most viewed articles Jul.2018
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 41 No. 7
    Current Topics:New Insights into Neurozinc and Metallothioneins




  • Biol. Pharm. Bull. Vol. 41 No. 3
    Current Topics: Cutting-Edge Studies Using Artificial Membranes
  • Biol. Pharm. Bull. Vol. 40 No. 12
    Current Topics: Recent Progress in the Study of Vasoactive Modulators in Metabolic and Cardiovascular Diseases



feedback
Top